Monthly Archives: April 2016

This month, the EQuIPP platform that pharmacies and pharmacists use to determine how well they are performing added a new measure. The measure is entitled UHC 90-day Fill Rate. The an example of the measure and is shown below. This measure is only displayed by EQuIPP when viewing Goal: Full Measure Set. This is not a CMS measure; it......
Continue Reading →
The other day, I wrote about a case involving a medication for which the plan required to be filled at a specialty pharmacy. This was an example of fragmentation of care. In Pharmacy, fragmentation is often either financial, or the result of contractual requirements imposed by benefit managers or plans. Examples include: maintenance medications that are required be......
Continue Reading →
I am seeing more and more drugs that are being moved from traditional retail status, meaning that you can get them from your local pharmacy, to specialty-drug status, available only from a designated pharmacy. According to Specialty Pharmacy Times: specialty drugs or pharmaceuticals usually require specialty handling, administration, unique inventory management, a high level of patient monitoring,......
Continue Reading →
With the FTC considering the pending merger of Walgreens and Rite-Aid, the consequences of pharmacies owning PBMs may once again be considered. It has been several years since FTC approved the CVS  / Caremark merger, and the changes and consequences of that merger are now visible. It is imperative that these issues of potential conflicts of interest are revisited. For an excellent overview, read: Big......
Continue Reading →